Galvani Bioelectronics is dedicated to the development of bioelectronic medicines–a new class of medicines consisting of miniaturized, implantable devices. Formed through a partnership between global healthcare company, GSK, and leading technology company, Verily Life Sciences, Galvani Bioelectronics combines the complementary expertise of its parent companies to enable the research, development and commercialization of bioelectronic therapies.
